The role of anti-pericyte antibodies in the development of diabetic retinopathy

Joanna Adamiec; Jolanta Oficjalska-Młyńczak

Full text

3/2005 vol. 107

Review paper

The role of anti-pericyte antibodies in the development of diabetic retinopathy

Joanna Adamiec ¹

,

Jolanta Oficjalska-Młyńczak ¹

Katedra i Klinika Okulistyki Akademii Medycznej im. Piastów Śląskich we Wrocławiu

Klinika Oczna 2005, 107(7-9): 541-543

Data publikacji online: 2005/09/22

Article file

129_3_2005_ADAMIEC_ROLA.pdf

AMA

Adamiec J, Oficjalska-Młyńczak J. The role of anti-pericyte antibodies in the development of diabetic retinopathy. Klinika Oczna / Acta Ophthalmologica Polonica. 2005;107(3):541-543.

APA

Adamiec, J., & Oficjalska-Młyńczak, J. (2005). The role of anti-pericyte antibodies in the development of diabetic retinopathy. Klinika Oczna / Acta Ophthalmologica Polonica, 107(3), 541-543.

Chicago

Adamiec, Joanna, and Jolanta Oficjalska-Młyńczak. 2005. "The role of anti-pericyte antibodies in the development of diabetic retinopathy". Klinika Oczna / Acta Ophthalmologica Polonica 107 (3): 541-543.

Harvard

Adamiec, J., and Oficjalska-Młyńczak, J. (2005). The role of anti-pericyte antibodies in the development of diabetic retinopathy. Klinika Oczna / Acta Ophthalmologica Polonica, 107(3), pp.541-543.

MLA

Adamiec, Joanna et al. "The role of anti-pericyte antibodies in the development of diabetic retinopathy." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 107, no. 3, 2005, pp. 541-543.

Vancouver

Adamiec J, Oficjalska-Młyńczak J. The role of anti-pericyte antibodies in the development of diabetic retinopathy. Klinika Oczna / Acta Ophthalmologica Polonica. 2005;107(3):541-543.

SUBMIT YOUR PAPER

Share

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications